Crossmark

Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers

Crossref DOI link: https://doi.org/10.1186/s12645-022-00119-w

Published Online: 2022-06-03

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Chang Hyun

Kim, Byoung Deok

Lee, Tae Hwa

Kim, Hyeon Kyun

Lyu, Min Jeong

Yoon, Young In

Goo, Yoon Tae

Kang, Myung Joo

Lee, Sangkil

Choi, Young Wook
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2019R1A2C2002510, 2022R1A2B5B02001794)
License Information

Text and Data Mining valid from 2022-06-03

Version of Record valid from 2022-06-03
More Information

Article History

Received: 28 November 2021

Accepted: 25 April 2022

First Online: 3 June 2022

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below